Author:
Hernandez Diego,Giri Pratyush,von Both Alexander,Schlander Michael
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue M‑H, Barth J, Hoffmann H, Potter V (2018) Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: a retrospective observational study (LuCaBIS). Cancer Treat Res 124:298–309
2. Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA 315:272–283
3. Hernandez D, Hernandez-Villafuerte K, Schlander M (2021) Messung der Kosten von Krebserkrankungen in Deutschland. Forum 36:406–410
4. Hernandez D, Von Both A, Schlander M (2022) Krankheitslast von Prostatakrebs in Deutschland: Epidemiologie und Kosten. Forum 37:227–243
5. Ihbe-Heffinger A, Paessens B, Berger K, Shlaen M, Bernard R, Von Schilling C, Peschel C (2013) The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care—an observational analysis on non-small-cell lung cancer patients. Support Care Cancer 21:1665–1675
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献